- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03329703
Project UPLIFT for Psychogenic Non-Epileptic Seizures (PNES)
The Feasibility of Project UPLIFT for the Treatment of Psychogenic Non-Epileptic Seizures
Developed by researchers from the Centers for Disease Control and Prevention (CDC), Project UPLIFT (Using Practice and Learning to Increase Favorable Thoughts) is a group telephone program designed to improve depression for people with epilepsy. Project UPLIFT uses evidence-based approaches of cognitive-behavioral therapy (CBT) and mindfulness-based cognitive therapy to help people manage and prevent symptoms of depression.
For people with psychogenic non-epileptic seizures, there are few treatment options for depression that address the relationship between mood and seizures. There is evidence that mindfulness-based therapy and cognitive therapy are both effective for people with non-epileptic seizures, both in treating depression and reducing seizure frequency. In this study, Project UPLIFT will be offered to patients with psychogenic non-epileptic seizures.
Project UPLIFT is facilitated by a trained clinician to groups of 4-8 patients over the telephone. The group will meet at a regular time, once a week, for 8 consecutive weeks. Participants will be assigned to one of two groups: an immediate-treatment or a waitlist control group which will begin Project UPLIFT 3 months after enrolling in the study.
Study Overview
Status
Intervention / Treatment
Detailed Description
Upon enrollment in the study, participants will be randomly assigned to one of two groups: an immediate-treatment group, or a 3-month waitlist control group. Both groups will be given surveys to complete online, and a seizure calendar to keep track of auras, seizures, and events. The immediate-treatment group will be scheduled to start Project UPLIFT with their trained facilitator. Each of the eight weekly sessions will take place at the same day of the week and at the same time, and will last approximately one hour. Participants will have the option of using a fake-name during the telephone calls to conceal their identity during the group telephone calls.
After the 8 weekly sessions, both groups will be given a second set of online surveys to complete individually. At this time, the waitlist control group will be scheduled to start Project UPLIFT with the trained facilitator. After the waitlist group completes the final session of Project UPLIFT, both groups will complete a third and final set of online surveys, thus concluding all study procedures.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New Hampshire
-
Lebanon, New Hampshire, United States, 03756
- Dartmouth-Hitchcock Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- History of psychogenic non-epileptic seizures, confirmed by study investigator.
- Literate
- Reliable telephone access
Exclusion Criteria:
- Dual diagnosis of PNES with epilepsy.
- Presence of serious mental illness that will impair ability to participate.
- Presence of active suicidal ideation at baseline with intention to act.
- Severe mental disability or estimated intelligent quotient (IQ) less than 70.
- No reliable telephone access.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Immediate-Treatment
This group will receive Project UPLIFT immediately after completing surveys.
|
A group, telephone-based intervention for depression that uses techniques from mindfulness-based therapy and cognitive therapy.
The intervention consists of 8 sessions occurring at the same time and day every week.
|
Active Comparator: Waitlist Control
This group will receive Project UPLIFT after waiting approximately 3 months to begin the intervention.
|
A group, telephone-based intervention for depression that uses techniques from mindfulness-based therapy and cognitive therapy.
The intervention consists of 8 sessions occurring at the same time and day every week.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
80% of participants who begin Session 1 of UPLIFT will complete 80% of the sessions.
Time Frame: 6 months
|
To test the feasibility of giving Project UPLIFT to patients with PNES
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in depression (Patient Health Questionnaire-9) before and after intervention.
Time Frame: 6 months
|
Change from baseline in depression scores, as reported in the Patient Health Questionnaire-9.
The PHQ-9 provides a total depression score ranging from 0-27, with higher score indicating more severe depression symptoms.
|
6 months
|
Change in seizure frequency as assessed by self-report seizure questionnaire.
Time Frame: 6 months
|
Change from baseline in seizure frequency on the self-report seizure questionnaire.
The self-report seizure questionnaire asks participants to report the number of seizures they have had in the previous week, month, and year.
There is no upper limit of the scale, and is not a standardized survey.
|
6 months
|
Change in anxiety (Generalized Anxiety Disorder-7) before and after the intervention.
Time Frame: 6 months
|
Change from baseline in anxiety scores, as reported on the Generalized Anxiety Disorder -7 survey.
The GAD-7 provides a total score ranging from 0-21, with a higher score indicating more severe anxiety symptoms.
|
6 months
|
Change in symptoms of Post-Traumatic Stress Disorder (PTSD Checklist-Civilian Version, PCL-C) before and after the intervention.
Time Frame: 6 months
|
Change from baseline in Post-Traumatic Stress Disorder scores as measured by the Post-Traumatic Stress Disorder Checklist - Civilian Version.
The PCL-C provides a total score of PTSD severity that ranges from 17-85, with higher score indicating higher symptom severity.
|
6 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Lindsay Schommer, APRN, Dartmouth-Hitchcock Medical Center
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- D17161
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
-
Gerbera Therapeutics, Inc.Not yet recruitingPostpartum Depression | Depression, Postpartum | Postnatal Depression | Post-partum Depression | Post-Natal DepressionUnited States
Clinical Trials on Project UPLIFT
-
Morehouse School of MedicineEmory UniversityCompletedEpilepsy | Depressive Symptoms | Anxiety Disorders and SymptomsUnited States
-
Emory UniversityThe University of Texas Health Science Center, Houston; National Institute... and other collaboratorsCompletedDepression | Epilepsy | Depressive Symptoms | Seizure DisorderUnited States
-
Duke UniversityCompletedSubstance Use | Mental HealthUnited States
-
Boise State UniversityNot yet recruitingSubstance Use | Perinatal Depression | Perinatal Anxiety | Telehealth
-
Indiana UniversityUniversity of Maryland, Baltimore; National Institute on Aging (NIA)RecruitingAlzheimer DiseaseUnited States
-
NYU Langone HealthCompletedHypertensionUnited States
-
Virginia Commonwealth UniversityJohns Hopkins University; University of Michigan; Boston Children's Hospital; Emory... and other collaboratorsCompletedDepression | Anxiety | Cystic FibrosisUnited States
-
University of UtahNational Institute of Nursing Research (NINR)CompletedPerinatal DepressionUnited States
-
Massachusetts General HospitalAmerican Cancer Society, Inc.Terminated
-
Harvard UniversityCompletedDepression | Stress | AnxietyUnited States